TP53 and neoplasm: Interestingly, PCI demonstrated superior anti-proliferative efficacy compared to Tas, consistent with previous studies indicating PCI’s ability to enhance acetyl-p53 (K381) in a dose-dependent manner, thereby suppressing tumor growth [18].